SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sanofi Signs pCPA Letter of Intent for Sarclisa in Canada

Sanofi said it completed negotiations with the pan-Canadian Pharmaceutical Alliance and signed a letter of intent for Sarclisa in first-line, transplant-ineligible multiple myeloma.

SNY

Related stories